Search Results

1 - 10 of 55 items :

  • "Mental health care" x
Clear All
The role of long term care centers in the Polish system of mental health care

References 1. Mazur I, Karnieja P, Jończyk J. Zdrowie psychiczne. Organizacja -Zarządzanie - Standardy. Wrocław: 2015. 2. A. Denys. Zagrożenia Zdrowia Publicznego. Wybrane zagadnienia, ABC Wolters Kluwer, Warszawa: 2014. 3. Kiejna A, Adamowski T, Piotrowski P, Moskalewicz J, Wojtyniak B, Świątkiewicz G et al. Epidemiology of mental disorders and access to mental health care. EZOP – Poland” – research methodology Psychiatria Pol. 2015; 49(1):5–13. 4. Załuska M. The community-based psychiatric care model and changes in the health system

Open access
The Development of Mental Health Policies in the Czech Republic and Slovak Republic since 1989

://www.politikon.cz/index.php/publicistika/6/2231-suasnystav-psychiatrickej-starostlivosti-na-slovensku. Centre for Mental Health Care Development. 2005. Politika péče o duševní zdraví - cesty k její realizaci [Mental Health Care Policy - Roads to Implementation]. Clasen, J. (1999). Comparative Social Policy: Concepts, Theories and Methods. Oxford: Blackwell Publishers. Dlouhý, M., Cosoveanu, G., Čižmárik, P., & Hinkov, H. (2010). Mental Health Policies in Four Eastern European Countries. Central European Journal of Public Policy. Vol.4, No 2

Open access
Implementing a psychosocial intervention DIALOG+ for patients with psychotic disorders in low and middle income countries in South Eastern Europe: protocol for a hybrid effectiveness-implementation cluster randomized clinical trial (IMPULSE)

employment and lead a productive life. However, LMICs in South Eastern Europe have neither the funding nor enough qualified staff to provide such specialised services ( WHO, 2014 ; Maric et al., 2019 ) Therefore, there is an urgent need to implement low-cost, easily deliverable psychosocial interventions to expand the access to care and alleviate the suffering of these patients and their families. This study aims to assess the effectiveness and the implementation of a psychosocial intervention called DIALOG+ in community-based mental health care services in five South

Open access
Affective Labor and Governmental Policy: George W. Bush's New Freedom Commission on Mental Health

, and Antonio Negri. Multitude: War and Democracy in the Age of Empire. New York: Penguin Books, 2004. Hogan, Michael F. [Chair]. Achieving the Promise: Transforming Mental Health Care in America. Final Report (July, 2003) // http://www.mentalhealthcommission.gov/reports/Finalreport/downloads/downloads.html Iglehart, John K. "The Mental Health Maze: Some Progress, Many Pitfalls." Health Affairs 25 (2006): 599. Johnson, Davi. "Psychiatric Power: The Post-Museum as a Site of Rhetorical

Open access
Evaluation of the Patients’ Satisfaction with Psychiatric Health Care Services with an Adapted PIPEQ-OS Tool

veselības nozarē [European Union Structural Funds in Health Care]. Available from: http://esfondi.vm.gov.lv/lat/2014__2020gads/ (accessed 12.12.2018). Awara, M., Fasey, C. (2008). Patients’ satisfaction and quality of care in psychiatric out-patient settings. J. Mental Health , 17 (3), 327–335. Barbato, A., Bajoni, A., Rapisarda, F., D'Anza, V., De Luca, L. F., Inglese, C., Iapichino, S., Mauriello, F., D'Avanzo, B. (2014). Quality assessment of mental health care by people with severe mental disorders: A participatory research project. Commun. Mental

Open access
Clinical and Sociodemographic Characteristics in First-Episode Psychosis Patients in a Rural Region of Latvia

REFERENCES Anderson, K. K., Fuhrer, R., Malla, A. K. (2010). The pathways to mental health care of first-episode psychosis patients: A systematic review. Psychol. Med., 40 (10), 1585–1597. Andreasen, N. C., Arndt, S., Miller, D., Flaum, M., Nopoulos, P. (1995). Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: An overview and update. Psychopathology , 28 (1), 7–17. Anonymous (1992). International Classification of Diseases. 10 th revision (ICD-10

Open access
Capabilities for handling complex substance abuse problems and its relationship to the treatment system: using the DDCAT instrument to explore local treatment systems in Finland

ABSTRACT

BACKGROUND - Mental health problems in Finland have been the responsibility of the health care, and substance abuse problems have been handled within social care. In 2009, a national reform aiming at integrating mental health and substance abuse treatment systems (SATS) was launched. The critics of integration were concerned that it implies a medicalization and a narrowing of the social care goals. AIM - This article analyses to what extent integration of mental health and SATS affect the capability to treat co-occurring substance abuse and mental health problems. A secondary aim is to assess the utility of the DDCAT (Dual Diagnosis Capability in Addiction Treatment) instrument in a Finnish context. DATA - The study is based on group interviews, using DDCAT, in six Finnish municipalities, three with integrated and three with separate mental health care and SATS. The assessment pertains to the main outpatient unit in the city.

RESULTS - The dual diagnosis treatment capability did not depend on the system-level integration. Two municipalities where SATS was administratively separate from mental health care were able to achieve high dual diagnosis capability ratings while in one municipality with system level integration this capability was not very high. The DDCAT instrument puts an emphasis on medical staff and competence.

CONCLUSIONS - Strong, separate local SATS may adapt to the integration demands or needs by strengthening their psychiatric competence. This solution can result in treatment that is equally competent in treating mental health and substance abuse problems as integrated systems. The DDCAT instrument can be useful in a Finnish context to measure medical competence to handle dual diagnoses, irrespective of system solutions. For a balanced measurement, the instrument should be complemented with a section mapping competence to handle co-occurring social problems

Open access
Is it time for baclofen to be included in the official recommendations concerning the treatment of alcoholism?

Abstract

Alcohol dependence and its treatment is not an exactly resolved problem. Based on the EZOP [Epidemiology of Mental Disorders and Accessibility of Mental Health Care] survey, which included a regular analysis of the incidence of mental disorders in the population of adult Polish citizens, we were able to estimate that the problem of alcohol abuse in any period of life affects even 10.9% of the population aged 18-64 years, and those addicted represent 2.2% of the country’s population. The typical symptoms of alcohol dependence according to ICD-10, include alcohol craving, impaired ability to control alcohol consumption, withdrawal symptoms which appear when a heavy drinker stops drinking, alternating alcohol tolerance, growing neglect of other areas of life, and persistent alcohol intake despite clear evidence of its destructive effect on life. At the moment, the primary method of alcoholism treatment is psychotherapy. It aims to change the patient’s habits, behaviours, relationships, or the way of thinking. It seems that psychotherapy is irreplaceable in the treatment of alcoholism, but for many years now attempts have been made to increase the effectiveness of alcoholism treatment with pharmacological agents. In this article we will try to provide a description of medications which help patients sustain abstinence in alcoholism therapy with particular emphasis on baclofen.

Open access
Strošek In Učinkovitost Zdravljenja Shizofrenije Z Atipičnimi Antipsihotiki V Sloveniji: Raziskava Stroškovne Učinkovitosti / The Cost And Effects Of Atypical Antipsychotic Agents In Patients With Schizophrenia In Slovenia: A Cost Effectiveness Study

Izvleček

Uvod: Zdravljenje z atipičnimi antipsihotiki predstavlja najpomembnejši način zdravljenja bolnikov z akutno shizofrenijo in predstavlja veliki strošek. V Sloveniji nam primanjkuje raziskav stroškovne učinkovitosti atipičnih antipsihotikov, ki jih lahko uporabimo v klinični praksi.

Namen: Osnovni namen raziskave je bil primerjava stroškov in učinkovitosti petih atipičnih antipsihotikov z največjim tržnim deležem v letu 2011 v Sloveniji. V raziskavo smo vključili aripiprazol, kvetiapin, paliperidon, risperidon in olanzapin.

Metode: Ciljna populacija v raziskavi so bili slovenski bolniki z akutno shizofrenijo. Vsak izmed petih antipsihotikov predstavlja glavno vejo odločitvenega drevesa. Terapevtska učinkovitost je bila določena kot verjetnost letne remisije. Ceno dnevnega zdravljenja s posameznim zdravilom smo pridobili iz podatkov tržnega deleža in prometa v letu 2011, stroške mentalnega zdravstvenega varstva v Sloveniji pa smo pridobili iz podatkov Zavoda za zdravstveno zavarovanje Republike Slovenije. Raziskava je bila zasnovana z vidika plačnika, tj. Zavoda za zdravstveno zavarovanje Republike Slovenije.

Rezultati: Zdravljenje z risperidonom je najcenejše, najučinkovitejše pa z olanzapinom. Strategija zdravljenja z risperidonom ima najmanjši kvocient med stroški in učinkovitostjo. Strategije zdravljenja z aripiprazolom, s kvetiapinom in paliperidonom so prevladujoče. Cene letnega zdravljenja so: 6.812 EUR za risperidon, 7.509 EUR za kvetiapin, 7.295 EUR za olanzapin, 8.229 EUR za aripiprazol in 8.044 EUR za paliperidon. Učinkovitosti, podane v deležu letne remisije, so: 0,605 - kvetiapin, 0,603 - aripiprazol, 0,671 - risperidon, 0,723 - olanzapin in 0,712 - paliperidon.

Sklep: Rezultati študije kažejo, da je najbolj stroškovno učinkovito zdravljenje akutne shizofrenije z risperidonom in olanzapinom

Open access
Evaluating the complex: Alternative models and measures for evaluating collaboration among substance use services with mental health, primary care and other services and sectors

perspective. Academy of Management Journal, 47, 795-817. Brousselle, A., Lamothe, L., Sylvain, C., Foro, A., & Perreault, M. (2010). Integrating services for patients with mental and substance use disorders: What matters? Health Care Management Review, 35(3), 212-223. Canadian Centre on Substance Abuse (in press). Best advice on collaboration for addiction and mental health care. Ottawa: Canadian Centre on Substance Abuse. Chalk, M., Dilonardo, J., and GelberRinaldo, S. (2011). Purchasing integrated services for substance use

Open access